Sanofi ADR

NASDAQ: SNY
$58.26
+$0.79 (+1.4%)
Closing Price on September 19, 2024

SNY Articles

This last weekend brought the first waves of picks for 2012.  Barron’s issued its “10 Favorite Stocks For 2012” and the stocks were just about all lower on Monday with a very weak stock...
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released the latest holdings of U.S.-listed equities as of September 30, 2011 and this is the second group of ‘L to Z’ in...
Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better than analysts expected, but worries persist that the company will be hit...
The House defeated a spending bill to fund the federal government passed September 30. (Reuters) United Technologies (NYSE: UTX) will buy Goodrich (NYSE: GR) for $16.5 billion. (Reuters) China’s...
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released the latest holdings of U.S.-listed equities as of June 30, 2011 and this is the second group of ‘M to Z’ in the...
Once patent protection expires on a prescription drug, the drug’s maker can take a serious beating in revenue and profitability. One way to make up for the loss is to get US Food & Drug...
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) is out with its new portfolio holdings as of March 31, 2011.  These have been broken down into two separate groups of ‘A to L’ and ‘M to Z’ so it...
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday morning. AmerisourceBergen Corp. (NYSE: ABC) Reiterated Buy and raised...
Microsoft Corporation (NASDAQ: MSFT) is about to get beyond the somewhat negative press of the Paul Allen behind it.  The software giant reports today after the close.  Thomson Reuters has...
BlackRock, Inc. (NYSE: BLK) is finally getting the respect it deserves.  The asset manager is being added to the S&P 500 Index.  The index had held this addition up for years due to the Bank of...
The proposed buyout of Genzyme Corporation (NASDAQ: GENZ) by Sanofi-Aventis (NYSE: SNY) should close this week.  We are about to get a new Genzyme security on the market and that will be the...
It is time for “The M&A Daily” and we have what might normally appear as a red flag alert here today.  Yesterday’s news that Sanofi-Aventis SA (NYSE: SNY) was borrowing $7 billion via...
It has finally happened.  Genzyme Corporation (NASDAQ: GENZ) is being acquired by Sanofi-Aventis (NYSE: SNY).  The deal should trade at a premium to the $74.00 cash component due to what is called...
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) is out with the new portfolio holdings as of December 31, 2010, so these are his new 2011 investments.  There were many changes in the prior groups due...
They call it “Merger Monday” for a reason.  Today’s news is not dominated by football hangovers.  It is dominated by a slew of headlines over mergers, mergers, and more mergers.  We compiled...